Latest filing published 19 Jun 2012 for ACHILLION PHARMACEUTICALS INC, €21k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
David P. Wright: trading record in brief
This profile gathers the share dealings of David P. Wright across 2 companies, led by Altimmune, Inc. and Achillion Pharmaceuticals Inc. The record holds 19 filings, for trades running from 3 August 2007 to 15 June 2012.
The open-market side counts 8 purchases for €135k alongside 2 sales for €105k. On balance, insiders were net buyers of €30k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 1 share grant and 2 option exercises. 2012 to date brings no purchases and 1 sale.
Half of the purchases are above €13k and half below.
The newest entry dates from 19 June 2012: an option exercise of €21k, in Achillion Pharmaceuticals Inc. The last insider purchase was made public on 14 December 2009, 6,174 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David P. Wright
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$2.66Common StockSEC:0001181431-12-037240:0
- 10,000 shares@ US$6.43Common StockSEC:0001181431-12-037240:1
- 12,500 shares@ US$1.05Common StockSEC:0001181431-11-049067:0
- 12,500 shares@ US$6.00Common StockSEC:0001181431-11-049067:1
- 25,000 shares@ US$1.16Common Stock, $0.0001 par value per shareSEC:0001104659-09-069830:0Canonical exit: 11 Mar 2010 (T+90)
- 37,185 sharesCommon Stock, $0.0001 par value per shareSEC:0001104659-09-003882:0
- 13,000 shares@ US$0.95Common StockSEC:0001104659-08-074141:0Canonical exit: 1 Mar 2009 (T+90)
- 700 shares@ US$0.98Common StockSEC:0001104659-08-073471:0Canonical exit: 23 Feb 2009 (T+90)
- 16,500 shares@ US$0.93Common StockSEC:0001104659-08-072715:0Canonical exit: 19 Feb 2009 (T+90)
- 45,300 shares@ US$0.96Common StockSEC:0001104659-08-072420:0Canonical exit: 17 Feb 2009 (T+90)
- 50,000 shares@ US$0.98Common StockSEC:0001104659-08-072420:1Canonical exit: 18 Feb 2009 (T+90)
- 7,500 shares@ US$2.91Common stock, par value $0.0001 per shareSEC:0001104659-08-036845:0Canonical exit: 26 Aug 2008 (T+90)
- 2,500 shares@ US$2.90Common stock, par value $0.0001 per shareSEC:0001104659-08-036845:1Canonical exit: 27 Aug 2008 (T+90)
- 50,541 sharesCommon Stock, $0.0001 par value per shareSEC:0001193805-07-002363:0
- 1,274 sharesCommon Stock, $0.0001 par value per shareSEC:0001193805-07-002363:1
- 100,000 sharesCommon Stock, $0.0001 par value per shareSEC:0001193805-07-002363:2
- 50,542 sharesCommon Stock, $0.0001 par value per shareSEC:0001193805-07-002143:0
- 1,274 sharesCommon Stock, $0.0001 par value per shareSEC:0001193805-07-002143:1
- 50,542 sharesCommon Stock, $0.001 par value per shareSEC:0001209191-07-046696:0
19 of 19 declarations
